Digital Diagnostics

Digital Diagnostics is a pioneering healthcare technology company dedicated to transforming global healthcare through the development and deployment of artificial intelligence diagnostic systems. Founded by Dr. Michael Abramoff, the company has achieved significant milestones in AI-driven healthcare, emphasizing ethical principles and patient-centric solutions with a mission to benefit patients by developing technology to make high-quality healthcare easier to access, affordable, and available to everyone. Digital Diagnostics is renowned for developing the first FDA-cleared autonomous AI diagnostic platform, LumineticsCore®, which provides a diagnosis without physician override. LumineticsCore detects diabetic retinopathy at the point-of-care, can close the eye exam for diabetes care gap, and facilitates timely interventions for patients. To further support connected care, Digital Diagnostics has developed SphereRx, a secure data platform that pairs with LumineticsCore to offer secure centralized access to exam results and allow monitoring of key performance metrics in real-time.